Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ijd.15391 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A rare severe acrodermatitis continua of Hallopeau treated with spesolimab.
J Dermatol
January 2025
Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Spesolimab in refractory paediatric acrodermatitis continua of Hallopeau, a case series.
J Eur Acad Dermatol Venereol
December 2024
Dermatology Hospital of Southern Medical University, Guangzhou, China.
Acrodermatitis Continua of Hallopeau Successfully Treated With Bimekizumab.
Dermatol Pract Concept
October 2024
IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico di Sant'Orsola, Dermatology Unit.
Acrodermatitis continua of hallopeau: aggravating factors and treatment outcomes of 96 patients.
J Dermatolog Treat
December 2024
Dermatology Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Background: Acrodermatitis continua of Hallopeau (ACH) is a rare pustular psoriasis variant predominantly affects the distal phalanges of the fingers and toes. However, data on aggravating factors and treatment outcomes is limited.
Objective: This study aims to analyze the aggravating factors and treatment outcomes of ACH in a three-tertiary-hospital in South China.
Is tofacitinib monotherapy also effective for the treatment of Acrodermatitis continua of Hallopeau?
Australas J Dermatol
December 2024
Zhejiang Provincial Key Laboratory of Traditional Chinese Medicine Cultivation for Arthritis Diagnosis and Treatment, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!